• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDS+ VIO 27IN 3-0 S/A SH-1; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDS+ VIO 27IN 3-0 S/A SH-1; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Catalog Number PDP311H
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/01/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint # (b)(4).H3 investigation summary: the product was returned to ethicon for evaluation.One empty labeled winding former and one suture piece were returned for analysis.Product code pdp311h.During the visual inspection of the sample, no breakage suture was observed.Even though the extreme was noted to be cut probably caused by a surgical instrument.The product code pdp311h contains an absorbable suture.As the sample was received open, the time of exposure to the environment cannot be determined.As per the condition of the returned sample, the functional test could not be performed.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.No conclusion could be reached as to what caused the reported complaint.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.H3 investigation summary: the product was returned to ethicon for evaluation.One open box with thirty representative unopened samples received for analysis.Product code pdp311h.Following the sampling plan, a visual inspection was conducted on thirteen samples.The packets were open, and the swage and attachment area were noted to be as expected.These ones were tested to verify the dispensability of the sutures, and it was not possible in all samples due to the suture being found hard to release from the tray by applying excessive force.Due to this inconsistency, the remaining twenty-three samples were tested to verify the dispensability of the sutures, and it was not possible in all samples due to the suture being found hard to release from the tray by applying excessive force.Based on the information currently available, the indispensable suture was identified during the investigation of the sample received.This product issue will be addressed through the ethicon quality system.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
 
Event or Problem Description
It was reported that a patient underwent an orthopedic trauma surgery in july 2025 and suture was used.During the procedure, it was reported that the suture was broken when the surgeon attempted to sew muscles.Total 3 products occurred suture breakage issue.Changed another one to complete the surgery.There is no report on patient's injury.There will return 3 actual products and 33 representative samples for analysis.No additional information could be provided.No adverse patient consequences were reported.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 8/20/2025.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected information: h6 investigational codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDS+ VIO 27IN 3-0 S/A SH-1
Common Device Name
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
calle durango #2751
ciudad juarez 32575
MX   32575
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
3035526892
MDR Report Key22849220
Report Number2210968-2025-09535
Device Sequence Number8403377
Product Code NEW
UDI-Device Identifier10705031048003
UDI-Public(01)10705031048003(17)45869(10)TJMEPJ
Combination Product (Y/N)Y
Initial Reporter CountryCH
PMA/510(K) Number
K061037
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2025
Device Catalogue NumberPDP311H
Device Lot NumberTJMEPJ
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/11/2025
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/22/2025
Supplement Date Received by Manufacturer07/22/2025
Initial Report FDA Received Date08/20/2025
Supplement Report FDA Received Date08/20/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/10/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-